Pliant Therapeutics Inc (PLRX)
12.98
+0.13
(+1.01%)
USD |
NASDAQ |
Nov 22, 16:00
12.99
+0.01
(+0.08%)
After-Hours: 20:00
Pliant Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.0187 |
| March 31, 2023 | 0.0177 |
| December 31, 2022 | 0.0317 |
| September 30, 2022 | 0.0294 |
| June 30, 2022 | 0.0668 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.0668
Maximum
Jun 2022
0.011
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Haemonetics Corp | 1.394 |
| Marker Therapeutics Inc | -- |
| Aligos Therapeutics Inc | 0.00 |
| Korro Bio Inc | -- |
| CEL-SCI Corp | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 445.66M |
| Total Liabilities (Quarterly) | 99.84M |
| Shareholders Equity (Quarterly) | 345.82M |